3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
5
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
29
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Triple Negative Breast Neoplasms
15
Lung Neoplasms
10
Colorectal Neoplasms
8
Neoplasm Metastasis
7
Esophageal Squamous Cell Carcinoma
7
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Esophageal Neoplasms
5
Ovarian Neoplasms
4
Biliary Tract Neoplasms
4
Head and Neck Neoplasms
3
Gallbladder Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Vaccinia
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms by Site
2
Neoplasms
2
Locally Advanced Pancreatic Cancer
2
Gastrointestinal Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Advanced Solid Tumors
2
Adenocarcinoma
2
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Interventions
Gemcitabine
3
Radiotherapy, Intensity-Modulated
2
Albumin-Bound Paclitaxel
2
Taxes
1
S 1 (combination)
1
Radiotherapy
1
Panitumumab
1
Optical Imaging
1
Irinotecan
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Adenocarcinoma
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT06250972
2025-08-07
PTCA199-11
Fudan University
Phase 3
Recruiting
210 enrolled